ART induces cell cycle arrest in human prostate cancer, human gallbladder cancer, and human breast cancer cells by downregulating the expression of cyclin-dependent kinases CDK2 and CDK4 (81–83). This evidence concerns the gene CDK2 and Familial prostate cancer.